Literature DB >> 30324517

The Study of Brain Tumor Stem Cell Migration.

Montserrat Lara-Velazquez1,2, Rawan Al-Kharboosh1,3, Luis Prieto3, Paula Schiapparelli1, Alfredo Quiñones-Hinojosa4.   

Abstract

Despite many advancements in brain cancer therapeutics, brain cancer remains one of the most elusive diseases with high migratory capacity and a dismal prognosis. It is well established that tumor stem cells utilize the same available migratory machinery that normal cells employ. Some of the major determinants of brain tumor stem cell migration are their cytoskeletal rearrangements and adhesion dynamics. This phenomenon allows brain tumor stem cells to perpetually migrate, invade, and repopulate in a vicious cycle leading to tumor expansion and invasion at tumor boundaries. In order to dissect the enabling factors that allow for this process to be hijacked, we have identified relevant assays to enable measurements of neoplastic migration such as Boyden Chamber, 3D chemogradient chamber, Nanopattern, and wound healing assays. Our purpose is to report the complex experimental platforms seen in the literature today and provide an optimal platform to kick off your studies in this field.

Entities:  

Keywords:  BTICs migration; Boyden chamber; Chemogradient chamber; Nanopattern; Transwell; Wound healing assay

Mesh:

Year:  2019        PMID: 30324517      PMCID: PMC6379916          DOI: 10.1007/978-1-4939-8805-1_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

Review 1.  At the leading edge of three-dimensional cell migration.

Authors:  Ryan J Petrie; Kenneth M Yamada
Journal:  J Cell Sci       Date:  2013-02-01       Impact factor: 5.285

Review 2.  Plasticity of cell migration: a multiscale tuning model.

Authors:  Peter Friedl; Katarina Wolf
Journal:  J Cell Biol       Date:  2009-12-01       Impact factor: 10.539

3.  Migration Phenotype of Brain-Cancer Cells Predicts Patient Outcomes.

Authors:  Chris L Smith; Onur Kilic; Paula Schiapparelli; Hugo Guerrero-Cazares; Deok-Ho Kim; Neda I Sedora-Roman; Saksham Gupta; Thomas O'Donnell; Kaisorn L Chaichana; Fausto J Rodriguez; Sara Abbadi; JinSeok Park; Alfredo Quiñones-Hinojosa; Andre Levchenko
Journal:  Cell Rep       Date:  2016-06-09       Impact factor: 9.423

Review 4.  In vitro cell migration and invasion assays.

Authors:  Nina Kramer; Angelika Walzl; Christine Unger; Margit Rosner; Georg Krupitza; Markus Hengstschläger; Helmut Dolznig
Journal:  Mutat Res       Date:  2012-08-23       Impact factor: 2.433

Review 5.  Initial steps of metastasis: cell invasion and endothelial transmigration.

Authors:  Franziska van Zijl; Georg Krupitza; Wolfgang Mikulits
Journal:  Mutat Res       Date:  2011-05-12       Impact factor: 2.433

6.  Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151.

Authors:  Jessica Tilghman; Paula Schiapparelli; Bachuchu Lal; Mingyao Ying; Alfredo Quinones-Hinojosa; Shuli Xia; John Laterra
Journal:  Neoplasia       Date:  2016-03       Impact factor: 5.715

  6 in total
  3 in total

1.  IDH-wild-type glioblastoma cell density and infiltration distribution influence on supramarginal resection and its impact on overall survival: a mathematical model.

Authors:  Shashwat Tripathi; Tito Vivas-Buitrago; Ricardo A Domingo; Gaetano De Biase; Desmond Brown; Oluwaseun O Akinduro; Andres Ramos-Fresnedo; Wendy Sherman; Vivek Gupta; Erik H Middlebrooks; David S Sabsevitz; Alyx B Porter; Joon H Uhm; Bernard R Bendok; Ian Parney; Fredric B Meyer; Kaisorn L Chaichana; Kristin R Swanson; Alfredo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2021-10-29       Impact factor: 5.408

2.  Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma.

Authors:  Tito Vivas-Buitrago; Ricardo A Domingo; Shashwat Tripathi; Gaetano De Biase; Desmond Brown; Oluwaseun O Akinduro; Andres Ramos-Fresnedo; David S Sabsevitz; Bernard R Bendok; Wendy Sherman; Ian F Parney; Mark E Jentoft; Erik H Middlebrooks; Fredric B Meyer; Kaisorn L Chaichana; Alfredo Quinones-Hinojosa
Journal:  J Neurosurg       Date:  2021-06-04       Impact factor: 5.408

3.  Suppressor of fused associates with dissemination patterns in patients with glioma.

Authors:  María Peris-Celda; Josefa Carrión-Navarro; Irina Palacín-Aliana; Pilar Sánchez-Gómez; Ricardo Prat Acín; Noemi Garcia-Romero; Angel Ayuso-Sacido
Journal:  Front Oncol       Date:  2022-08-24       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.